Lattulosio Eg

Lactulose, the active ingredient in Lattulosio Eg, is an osmotic laxative presented as an oral formulation for oral use. It is used to relieve constipation and to reduce blood ammonia levels in patients with hepatic encephalopathy, particularly in adult populations.

GNH USA supplies Lattulosio Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution.

Lactulose is employed in the management of gastrointestinal and hepatic conditions where reduction of intestinal ammonia or promotion of bowel movements is required.

- Constipation: Facilitates bowel movements by increasing water content in the colon, relieving occasional or chronic constipation. - Hepatic encephalopathy: Lowers intestinal ammonia absorption, helping to prevent or treat episodes of hepatic encephalopathy in patients with liver disease.

Lactulose may cause a range of gastrointestinal and systemic reactions, most of which are mild and transient.

Common Side Effects: - Bloating: sensation of abdominal fullness. - Flatulence: increased intestinal gas. - Abdominal cramps: mild to moderate discomfort. - Diarrhea: loose stools, especially at higher doses. - Nausea: feeling of sickness. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: especially hyponatremia or hypokalemia. - Dehydration: due to excessive fluid loss. - Allergic reaction: rash, itching, or swelling. - Severe abdominal pain: persistent or worsening pain. - Acute hepatic decompensation: rare worsening of liver function.

Before initiating lactulose therapy, consider the following safety measures.

- Assess renal function: use with caution in severe renal impairment. - Monitor electrolytes: watch for hyponatremia or potassium loss. - Avoid abrupt discontinuation: may lead to rebound constipation. - Use cautiously in diabetic patients: monitor blood glucose as lactulose can affect carbohydrate metabolism. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lactulose can interact with other medications that affect electrolyte balance or gastrointestinal function.

Major Interactions (Avoid): - Antibiotics (e.g., neomycin): may reduce lactulose efficacy by altering gut flora. - Magnesium‑containing laxatives: additive osmotic effect can cause severe dehydration. - Loop or thiazide diuretics: increased risk of electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Antacids: may change colonic pH and affect lactulose activity. - Metformin: potential for additive gastrointestinal side effects. - Probiotics: generally safe but may modify gut flora dynamics.